Semaglutide: First Global Approval [PMID: 29363040] Laboratory literature summary: Semaglutide: First Global Approval
doi: 10.3389/fendo.2022.821113 Received 23 November 2021 Accepted 07 February 2022 Published 20 April 2022 Volume 13 - 2022 Edited by Paolo Moghetti, University of Verona, Italy Reviewed by Antonio Aversa, University of Catanzaro, Italy Updates Copyright 2022 Pelusi
September 18-21, 2026 Save $3,605 when you become an IAPAM member and register to attend all 4-days!
A note for vegetarians and vegans: Most collagen supplements and collagen waters are not vegan or vegetarian because they're primarily derived from animal bones and proteins
A researcher who experiences a 7 BPM resting heart rate increase but is losing weight steadily, feeling well, and has normal blood pressure is not necessarily best served by reducing their dose
Also, adding a weight loss drug to other prescribed treatments can increase the risk of drug interactions